...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZEN-3694 and Enzalutamide 2b Trial

" In December he had mentioned that they could be unlocking some significant value in the "near future". 

Hahahahhahahaha,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,hahahahhahahahhahahahaha,,,,,,,,,,,,,,,,,,,,hahhahahahahhaha......thats hilarious,,,,,,,,,,,,Don said,,,,,,,,,,,,,,,,,,,,,,,,,,hahahahahhhahahahahahahha,,,,,,,,,,,,,,,,,,lmao!,,,,,,I have a pain in my side........it should actually be a tik tok,,,,,,,!!!!!!!!!!!!!!!!!!!!!

Share
New Message
Please login to post a reply